UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
by Kim Yun-mi
2019-03-13 12:43
‘Pay more attention to lipid control in stroke patients’
by Kim Yun-mi
2019-03-12 11:32
When will NOAC reversal agents be available in Korea?
by Kim Yun-mi
2019-03-07 15:52
Biogen seeks gene therapy pipeline for rare eye disease
by Kim Yun-mi
2019-03-06 14:41
Regulator expands XGEVA’s indication for use by multiple myeloma patients
by Kim Yun-mi
2019-03-04 16:02
라인
Korea’s drug exports hit record high in 2018, industry group says
by Kim Yun-mi
2019-02-27 13:08
‘Heat-not-burn cigarettes as risky as traditional ones’
by Kim Yun-mi
2019-02-26 15:45
Korean Society of Cardiometabolic Syndrome goes international
by Kim Yun-mi
2019-02-25 14:35
Lung cancer 2nd treatment Alunbrig likely to get insurance coverage
by Kim Yun-mi
2019-02-25 14:06
Will first-ever treatment for nonalcoholic fatty liver arrive?
by Kim Yun-mi
2019-02-22 15:29
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
by Kim Yun-mi
2019-02-21 15:13
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
by Kim Yun-mi
2019-02-21 15:10
84% of breast cancer patients are in working age in Korea
by Kim Yun-mi
2019-02-20 14:52
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
by Kim Yun-mi
2019-02-19 14:31
‘Hair loss drug Propesia works well for Koreans in long term’
by Kim Yun-mi
2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
by Kim Yun-mi
2019-02-18 14:23
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
by Kim Yun-mi
2019-02-15 14:31
Direct-acting antivirals reduce death risk for hepatitis C patients: study
by Kim Yun-mi
2019-02-14 14:59
Blood-thinning NOAC market expands 30% in 2018
by Kim Yun-mi
2019-02-14 12:12
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors
by Kim Yun-mi
2019-02-13 16:11
-
이전
11
12
13
14
15
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top